Delivery Order SPE2DR25D3103-SPE2DR26F9L10
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 with a ceiling value of $1,332.72. This competitively awarded, firm fixed-price delivery order is set to be completed by December 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside contract, the award reflects AmerisourceBergen's capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,870.88 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count) on December 11, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a ceiling value of $11,089.97. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion on September 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets in quantities of 30 on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed-price delivery order, valued at $3,972.54, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the company's role as...
- The Defense Logistics Agency awarded a delivery order valued at $26,399.23 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count units) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count units) valued at $1,605.86. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a routine pharmaceutical supply transaction...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Dapagliflozin 10 mg tablets in a 30-count package at a ceiling value of $1,333.77. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count) with a ceiling value of $2,438.22. This is a firm fixed price delivery order under an Indefinite Delivery Contract with no set-aside designation, reflecting a competitively awarded transaction. The order is scheduled for completion by December 9, 2025, with performance taking place at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a contract ceiling value of $1,949.87. This firm fixed-price delivery order, with an ultimate completion date of October 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count units) with a ceiling value of $1,999.08 under a firm fixed-price contract. This delivery order, with an ultimate completion date of November 28, 2025, represents a non-set-aside competitive procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9L10Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count units) with a ceiling value of $17,772.34. This competitive award, which carries a firm fixed price and completion date of December 3, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, maintains an extensive portfolio of medical product deliveries across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to meet federal procurement requirements through open competition. This delivery order for the diabetes medication aligns with the company's established role in supplying a broad spectrum of pharmaceuticals including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 12/1/25 |